Aaron Diamond AIDS Research Center

How to interpret these research links

Connected source records

The exact organization name Aaron Diamond AIDS Research Center appears in 9 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials9

Recruiting shown0

Roles2

SourceClinicalTrials.gov

Clinical trials

9 shown

A Study of Tucaresol in HIV-Infected Patients Who Are Taking Other Anti-HIV DrugsNCT00006209 · lead sponsor · 2000-06-01

UNKNOWN

Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIVNCT00002104 · lead sponsor

COMPLETED

Safety Study of Ibalizumab Subcutaneous Injection in Healthy VolunteersNCT01292174 · collaborator · 2011-02-01

COMPLETED

Standard Antiretroviral v. Multi-class Therapy in Acutely HIV-1 Infected Antiretroviral-Naïve Subjects (ADARC 2007-01)NCT00525733 · collaborator · 2007-10-01

COMPLETED

Study of the Antiviral and Immunological Effects of Intensification of Suppressive Antiretroviral Therapy With MaravirocNCT00703586 · collaborator · 2007-09-01

COMPLETED

Study of a Potential Preventive Vaccine Against HIV in Healthy VolunteersNCT00545987 · collaborator · 2007-09-01

COMPLETED

Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected AdultsNCT00252148 · collaborator · 2005-01-01

COMPLETED

Safety and Immunogenicity of a Plasmid HIV Vaccine in HIV Uninfected AdultsNCT00249106 · collaborator · 2003-12-01

COMPLETED

Observational Study of Treated and Untreated Acute and Early HIV-1 InfectionNCT00219934 · collaborator · 2002-02-01

COMPLETED

Drugs studied in this sponsor's trials

5 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Aaron Diamond AIDS Research Center as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.

maraviroc2

darunavir 800 MG1

raltegravir1

ritonavir 100 MG1

thalidomide1

maraviroc RxCUI 620216 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 2 trials darunavir 800 MG RxCUI 1359268 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial raltegravir RxCUI 719872 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial ritonavir 100 MG RxCUI 317488 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial thalidomide RxCUI 10432 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

collaborator7

lead sponsor2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.